CapsoVision, Inc. (CV)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$6.20-9.49%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · CV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | 13.9 | 13.6 | 11.8 | — |
| Cost of Revenues | 6.8 | 6.4 | 5.4 | — |
| Gross Profit | 7.1 | 7.2 | 6.4 | — |
| Operating Expenses & Income | ||||
| R&D Expenses | 21.6 | 18.3 | 15.1 | — |
| Operating Income | (30.2) | (25.5) | (19.9) | — |
| Earnings from Continuing Operations | ||||
| Other Non-Operating Income / Expenses | 0.4 | 0.2 | 0.0 | — |
| EBT, Incl. Unusual Items | (29.8) | (25.3) | (19.9) | — |
| Income Tax Expense | — | 0.0 | 0.0 | — |
| Net Income | ||||
| Net Income | (29.8) | (25.3) | (19.9) | — |
| Per Share | ||||
| Basic EPS | (0.60) | (1.03) | (9.85) | — |
| Diluted EPS | (0.60) | (1.03) | (9.85) | — |
| Revenue per Share | 0.28 | — | — | — |
| Basic Weighted Avg Shares | 49.9 | 24.6 | 2.0 | — |
| Diluted Weighted Avg Shares | 49.9 | 24.6 | 2.0 | — |
| Supplemental | ||||
| EBITDA | — | (25.3) | (19.7) | — |
| EBIT | (30.2) | (25.5) | (19.9) | — |
| Effective Tax Rate | — | — | -0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.